Related Experiment Video

Updated: Jul 13, 2026

A Mouse Model of Subchronic and Mild Social Defeat Stress for Understanding Stress-induced Behavioral and Physiological Deficits
08:10

A Mouse Model of Subchronic and Mild Social Defeat Stress for Understanding Stress-induced Behavioral and Physiological Deficits

Published on: November 24, 2015

DDT Administered to Neonatal Rats Induces Persistent Estrus Syndrome

W L Heinrichs, R J Gellert, J L Bakke

    Science (New York, N.Y.)
    |September 3, 1971
    PubMed

    Abstract:

    In the report "DDT administered to neonatal rats induces persistent estrus syndrome" by W. L. Heinrichs et al. (13 Aug., p. 642), line 4 in the last paragraph of column 1, page 643, should read " secretion of luteinizing hormone(LH)."

    More Related Videos

    Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice
    07:15

    Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice

    Published on: March 15, 2024

    A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice
    06:15

    A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice

    Published on: July 15, 2025

    Related Experiment Videos

    Last Updated: Jul 13, 2026

    A Mouse Model of Subchronic and Mild Social Defeat Stress for Understanding Stress-induced Behavioral and Physiological Deficits
    08:10

    A Mouse Model of Subchronic and Mild Social Defeat Stress for Understanding Stress-induced Behavioral and Physiological Deficits

    Published on: November 24, 2015

    Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice
    07:15

    Social Defeat Stress Model for Adolescent C57BL/6 Male and Female Mice

    Published on: March 15, 2024

    A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice
    06:15

    A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice

    Published on: July 15, 2025

    Related Concept Videos

    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

    Articles linked to this work by shared authors, journal, and citation graph.

    Advances in stem cell and other therapies for Huntington's disease: An update.

    Brain research bulletin·2023

    The essential human-machine interface for surgery: biological signals transmission.

    Surgical technology international·2011

    Initial evaluation of a shoulder arthroscopy simulator: establishing construct validity.

    Journal of shoulder and elbow surgery·2004

    Simulated learning environments in anatomy and surgery delivered via the next generation internet.

    Studies in health technology and informatics·2001

    G2H--graphics-to-haptic virtual environment development tool for PC's.

    Studies in health technology and informatics·2000

    Virtual body structures: a 3D structure development tool from visible human data.

    Studies in health technology and informatics·2000

    The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development.

    Science (New York, N.Y.)·2026

    Parsing heterogeneity in autism spectrum disorder.

    Science (New York, N.Y.)·2026

    Noise and diversity can boost stability.

    Science (New York, N.Y.)·2026

    In search of past genetics.

    Science (New York, N.Y.)·2026

    A viral origin for RNA-guided immunity.

    Science (New York, N.Y.)·2026

    Future forests.

    Science (New York, N.Y.)·2026

    Use of Two Biologics During Pregnancy: Infliximab and Vedolizumab: A Case Study.

    Therapeutic drug monitoring·2026

    Multidisciplinary Management of Pulmonary Arterial Hypertension in Pregnancy With Complex Congenital Heart Disease.

    JACC. Case reports·2026

    Understanding the Lived Experience of Fetal and Neonatal Alloimmune Thrombocytopenia: A Qualitative Study.

    AJP reports·2026

    Left ventricular assist device in pregnancy: case report of a near-term delivery with multidisciplinary support.

    European heart journal. Case reports·2026

    Leadless pacemaker implantation during pregnancy: Quantitative assessment of fetal radiation exposure.

    Heart rhythm O2·2026

    Towards an understanding of COVID-19-associated preeclampsia.

    Hypertension in pregnancy·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us